Hospital La Croix Rousse Hcl — Clinical Trial Site

28 Registered trials

14 Currently recruiting

Organisation

Hospital La Croix Rousse Hcl

Location

Lyon Cedex 04, France

Identifier

ORG-100032146

Address

103 Grande Rue De La Croix Rousse, 69317, France

Departments

Anesthésie Réanimation
Chirurgie ORL
gastroenterology
Hapatogastroenterologie
Hepato gastro enterology
Hepatogastroenterology
Hepatogastroenterology and digestive cancer department
Hepatology and Gastroenterology
HGE
INFECTIOLOGY
Infectious Diseases
Intensive Care Unit
Internal Medicine
Medical Oncology
oncology
Ophtalmologie
pneumology
Réanimation néonatale
Service d'Hépatologie et Gastroentérologie
Service d’hépatologie et Gastroentérologie du Professeur Zoulim
Service des Maladies Infectieuses et Tropicales

Clinical trials at this site (28)

Search interface

FirST lines of biologics in pAtients with ulceRaTivE colitis: a Randomised controlled trial Pending

2024-514964-24-00 ulcerative colitis 5
Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Duct… Pending

2024-518139-12-00 locally advanced or metastatic Pancreatic ductal adenoc 4
CHILURSO: Efficacy of Ursodeoxycholic Acid versus Corticosteroids for the Treatment of Cholestatic Hepatitis Secondary to Immunotherapy Pending

2025-521317-50-00 Cholestatic hepatitis induced by immune checkpoint inhi 5
PRODIGE 88-CIRCULATE PAC: Phase III multicentric, open-label, randomized study to investigate the efficacy of chemotherapy in patients with … Recruiting

2023-505046-26-00 Colon carcinoma 5 2026-05-07
A clinical study of islatravir and ulonivirine for people with HIV-1 who have not been treated before (MK-8591B-062) Recruiting

2025-522519-40-00 HIV 10 2026-03-16
WIthdrawal of DUpilumab in Severe Asthma : a randomised non-inferiority-controlled trial Recruiting

2024-516789-13-00 Severe asthma 6 2025-12-15
Immunogenicity and safety of the 20-Valent pneumococcal conjugate vaccine (PCV-20) administered during an acute febrile illness in adults Recruiting

2024-517411-73-00 Patient with medium or high risk for pneumococcal invas 6 2025-11-12
AKAPI: Amikacin Liposome Inhalation Suspension for treatment of Mycobacterium xenopi pulmonary infection: A prospective controlled open-labe… Recruiting

2023-506843-40-00 Mycobacterium xenopi pulmonary infection 5 2025-10-29
Efficacy of dexmedetomidine versus midazolam sedation on extubation time in mechanically ventilated preterm infants: a randomized controlled… Recruiting

2023-508785-16-00 Very preterm neonate (gestational age at birth < 32 WG) 5 2025-10-17
An open-label study to assess reduction of daily asthma medication with tezepelumab in patients 12 to 80 years of age with severe asthma Recruiting

2024-512113-41-00 Severe Asthma 5 2024-11-20
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-fibrosis) Recruiting

2023-509912-27-00 Metabolic Dysfunction-Associated Steatotic Liver Diseas 5 2024-11-07
Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With Bronchiectasis Recruiting

2023-504755-26-00 Bronchiectasis 4 2024-10-21
Personalized medicine for advanced biliary cancer patients Recruiting

2023-508100-38-00 Advanced Biliary Cancer (ABC) 5 2024-06-24
Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamo… Recruiting

2023-506308-24-00 Recurrent or metastatic head and neck squamous cell car 10 2024-05-22
PHase 3, Multicenter, RandOmized, Double-masked, PlacEbo-CoNtrolled Study of TInlarebant to EXplore Safety and Efficacy in the Treatment of … Recruiting

2023-503931-17-00 Geographic Atrophy 5 2024-03-28
Postoperative analgesic effect of orally administrated nefopam after a total knee arthroplasty: a randomized controlled trial (NefPO) Recruiting

2024-513796-40-00 Postoperative pain after a total knee arthroplasty 8 2021-06-29
Partial oral antibiotic treatment for bacterial brain abscess: An open-label randomised non-inferiority trial (ORAL) Recruiting

2023-505483-11-00 Brain abscess 6 2021-05-02
PEHRICCA : PErioperative CISGEM plus RILVEGOSTOMIG in High-Risk resectable Intrahepatic CholangioCarcinoma Ended

2025-521302-17-00 Hihg risk of cholangiocarcinoma intra hépatic resectabl 10 2026-05-26
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic … Ended

2023-503655-10-00 Systemic Lupus Erythematosus (SLE). 5 2023-11-20
Post-operative adjuvant treatment for HPV-positive tumours Ended

2024-516673-68-00 Human papillomavirus (HPV)-positive oropharyngeal cance 5 2020-10-27
Phase II multicentric study: efficacy evaluation of neo-adjuvant treatment associated with maintenance therapy by anti-PD1 immunotherapy on … Ended

2024-513027-16-00 Resectable mucosal melanomas 4 2018-05-28
Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection Ended

2023-509684-24-00 Hepatitis B 7 2024-10-31
Open-Label Study of Imdusiran (AB-729) in Combination with Intermittent Dosing of Durvalumab in Subjects with Chronic HBV Infection Ended

2023-509573-23-00 Chronic HBV Infection 4 2024-07-16
Efficacy and Safety of AXL-Inhibitor bemcentinib for the Treatment of Moderate COVID-19 (AXL-SolidAct) Ended

2022-500363-12-00 SARS CoV-2 (COVID-19) 4 2022-08-24